Webinar on

Cancer & Oncology

July 22-23, 2024

Theme – Current trends & concepts in the field of cancer and oncology

Organizing Committee

Check out our OCM

Submit Abstract

Submit Research Article

Registration

Few Speaker Slots are Available

Download Brochure Now

About Cancer & Oncology

Join us at the Webinar on Cancer & Oncology” taking place on July 22-23, 2024. with the theme “Cancer & Oncology Disease: Challenges and Breakthroughs”. 

This gathering warmly welcomes researchers, professors, clinicians, and professionals specializing in Cancer & Oncology. Engage in discussions on current challenges, share groundbreaking research, and forge connections with leading experts in oncology and related fields. Make sure not to miss Cancer Webinar 2024 for in-depth conversations on the latest developments in Cancer.

Speakers

Michal Linial

Hebrew University of Jerusalem, Israel

Nabil Djouder

University of Freiburg, Germany.

Joseph Yanai

University of Colorado, US

Rony Seger

weizmann institute of science, Isreal

Scientific Sessions

01. Oncology

02. Cancer Biology

03. Cancer Diagnosis & Treatment

04. Prevention of Cancer

05. Breast Cancer

06. Palliative Care

07. Clinical Oncology

08. Head & Neck Cancer

Who to attend Cancer Oncology Webinars?

Why to attend Cancer Oncology Webinars?

Media Partners & Collaborations

Event Summary

Join our upcoming webinar for a comprehensive exploration of cutting-edge developments. Engage with top experts in the field, network with peers worldwide, and gain invaluable insights into the latest trends and tactics. We’ve extended invitations to globally renowned keynote speakers, experts, brand ambassadors, and industry leaders, who will graciously share their insights and ideas with our esteemed webinar attendees.

Don’t miss this opportunity to expand your knowledge and stay ahead of the curve. Register now to secure your spot!”

The webinar is entirely virtual and accessible from anywhere with an internet connection. Specific dates and times for the event are provided on the webinar website.

Abstract submission guidelines and deadlines will be provided on the webinar website. Please refer to these guidelines when preparing and submitting your abstract for consideration.

Each Keynote Presenter will have 30-45 minutes, while Oral Presenter will have 20-25 minutes for presentation including Q/A session.

Each Poster Presenter will have 10-15 minutes for presentation including Q/A.

All presenters are requested to present their paper only in English.

We do not provide any translators during presentations. However, you can hire your own translator for the presentation.

Registration details, including instructions and fees (if applicable), will be available on the webinar website.

For further assistance or inquiries regarding the webinar, please contact our webinar organizers at [support@stripewebinars.com or +1 424 382 0198]. We’re here to help!

Contact Us

If you ever need assistance or have questions, please don’t hesitate to reach out to our dedicated support team.
Call Back Request

WhatsApp Now

We use essential cookies to make our site work. With your consent, we may also use non-essential cookies to improve user experience and analyze website traffic. By clicking “Accept,” you agree to our website's cookie use as described in our Cookie Policy. You can change your cookie settings at any time by clicking “Preferences.”

Michal Linial

Hebrew University of Jerusalem, Israel

Professor of Biochemistry and Bioinformatics at the Hebrew University of Jerusalem (HUJI).[3] Linial is the Director of The Sudarsky Center for Computational Biology at HUJI.[4][5] Since 2015, she is head of the ELIXIR-Israel node (European life-sciences Infrastructure for biological Information).[6]Linial was elected a fellow of the International Society for Computational Biology (ISCB) in 2016, for outstanding contributions to the fields of computational biology and bioinformatics, and served on the Board of Directors (2005–2016), and as a Vice-President (2007–2016), of the ISCB Hebrew University,

Nabil Djouder

University of Freiburg, Germany.

Nabil Djouder, born in France, obtained his PhD in Molecular Pharmacology from the University of Strasbourg (France) and the University of Freiburg (Germany), where he worked in the laboratory of K. Aktories. He studied the molecular mechanisms underlying the activation of mast cells by cross-linking high affinity antigen receptors (Fcε-RI) and the involvement of small GTPases from the Rho family in this activation.

In 2001, he moved to Basel (Switzerland) as a postdoctoral research fellow and joined the laboratory of W. Krek at the Novartis Friedrich Miescher Institute. He has since worked in the field of growth control, cancer, and associated metabolic disorders. Most of his research focuses on the mTOR/S6K pathway and the integration of growth factors, nutrients, and energy homeostasis.

Joseph Yanai

University of Colorado, US

1972 – Ph.D. Univ. of Colorado.
1978 – Present, Lecturer, Senior Lecturer; Associate Professor; Professor.
1991 – Present, Professor (Adjunct); Department of Pharmacology, Duke University Medical School, Durham, North Carolina, USA

Rony Seger

weizmann institute of science, Isreal

Rony continues to work in field of MAPK signaling and his achievements include: 1) Development of the first anti phospho antibodies for the study of MAPK activity; 2) Identification and study the role of alternatively spliced isoforms of ERKs; and 3) Elucidation of mechanisms that govern the subcellular localization of MAPK components, in particular their mechanism of nuclear translocation. 4) Use of the nuclear translocation as anti cancer and inflammation target.

He got Excellent Research Award of HKUST School of Engineering in 2012. He obtained Gold Medal and The Best Award in the Invention & Innovation Awards 2014 held at the Malaysia Technology Expo (MTE) 2014, which was hosted in Kuala Lumpur, Malaysia, on 20-22 Feb 2014. He is a Member of EU Academy of Sciences (EUAS) since July 2017.